|
Re: Heart failure study
|
6
|
Resverlogix Corp.
|
Feb 09, 2021 01:06PM
|
|
Re: Resverlogix Reports Positive FDA Type B Meeting on Design Issues Relating to a Proposed Phase 2a Kidney Dialysis Trial
|
6
|
Resverlogix Corp.
|
Feb 23, 2017 10:47AM
|
|
Re: Response from Sarah -were still a go
|
6
|
Resverlogix Corp.
|
Dec 02, 2021 07:52PM
|
|
New PAH drug
|
6
|
Resverlogix Corp.
|
May 07, 2024 09:37AM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
6
|
Resverlogix Corp.
|
Mar 18, 2021 09:57AM
|
|
Big Volume (for RVX)
|
6
|
Resverlogix Corp.
|
Feb 04, 2021 01:56PM
|
|
Re: Questions about the Medison licensing agreement....
|
6
|
Resverlogix Corp.
|
Jan 12, 2018 08:40AM
|
|
Re: Questions about the Medison licensing agreement....
|
6
|
Resverlogix Corp.
|
Jan 12, 2018 08:50AM
|
|
Re: Cart...
|
6
|
Resverlogix Corp.
|
Jun 03, 2021 01:40PM
|
|
Re: New Publication
|
6
|
Resverlogix Corp.
|
Feb 28, 2023 04:26PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
6
|
Zenith Epigenetics
|
Feb 09, 2022 01:51PM
|
|
Re: Zenith Payoff of Citi?
|
6
|
Resverlogix Corp.
|
Apr 05, 2017 06:30PM
|
|
Re: Sorry fuzz, believe I copied one of yours
|
6
|
Resverlogix Corp.
|
Oct 24, 2016 06:17PM
|
|
Re: Hypothetical thought
|
6
|
Zenith Epigenetics
|
Aug 21, 2024 11:43AM
|
|
Re: Still waiting for that BETonMACE CKD sub-study/management
|
6
|
Resverlogix Corp.
|
Jun 16, 2020 01:22AM
|
|
Re: Interesting Post: Fundamentals6
|
6
|
Resverlogix Corp.
|
Oct 01, 2016 02:01PM
|
|
Re: ...is anybody out there at the AGM...?
|
6
|
Resverlogix Corp.
|
Sep 30, 2015 04:57PM
|
|
Re: Resverlogix announces HEPALINK debenture $6mill
|
6
|
Resverlogix Corp.
|
May 05, 2021 07:03PM
|
|
Re: Narmac
|
6
|
Resverlogix Corp.
|
Aug 21, 2024 11:50AM
|
|
A few thoughts
|
6
|
Resverlogix Corp.
|
Feb 28, 2016 03:50PM
|
